Cognitive supplement UK: what the evidence actually shows

Most cognitive supplements sold in the UK are built on weak evidence, inflated claims, and doses too low to matter. A handful of ingredients — creatine chief among them — have genuine human trial data behind them. In one randomised controlled study, 5g of creatine daily produced measurable improvements in working memory in healthy adults within weeks. That's the bar. Most products don't clear it.

evidence-actually-shows">What the evidence actually shows

I'll be honest: the cognitive supplement space in the UK is mostly noise. Walk into any health food shop and you'll find shelves of products making vague promises with no numbers attached. So I went to the primary literature instead.

Creatine is where the strongest signal sits. Sandkühler et al. (2023) ran a double-blind, placebo-controlled RCT in healthy young adults and found that 5g of creatine monohydrate daily produced statistically significant improvements in working memory tasks compared to placebo. That's a clean study. Proper controls, meaningful outcome measures, not just a self-reported "I felt sharper."

The broader picture is similarly encouraging. Forbes et al. (2022) reviewed the existing literature on creatine and brain function and concluded that supplementation may support cognitive processing — particularly under conditions of mental fatigue or sleep deprivation — with effect sizes that are modest but consistent across multiple trials. And McMorris et al. (2008) found that creatine supplementation may support cognitive performance in elderly individuals, with particular effects on tasks requiring speed of processing.

Beyond creatine, the evidence thins out considerably. That doesn't mean other ingredients are worthless — it means the human trial data is limited, and I'd be overstating things to claim otherwise. I'll get into specifics below.

What's biologically happening: the mechanisms worth understanding

The brain is metabolically expensive. It accounts for roughly 20% of the body's total energy consumption despite being about 2% of body weight. That energy comes almost entirely from ATP — and ATP synthesis depends on phosphocreatine stores in neural tissue.

When cognitive demand is high, phosphocreatine acts as a rapid buffer, donating a phosphate group to ADP to regenerate ATP quickly. The problem is that brain creatine stores are finite and not always optimally saturated — particularly in people who eat little or no red meat, since dietary creatine is the primary source outside of supplementation.

Candow et al. (2023) reviewed the neurological mechanisms in detail and noted that oral creatine supplementation does appear to cross the blood-brain barrier and may raise cerebral phosphocreatine concentrations, which could support neural energy availability during cognitively demanding tasks. The word "may" is doing real work in that sentence — the human imaging data is still relatively sparse, but it's directionally consistent.

Separately, there's the gut-brain axis. Sarkar et al. (2017) outlined how gut bacteria may influence neurotransmitter production and stress signalling via the vagus nerve — a pathway that has attracted serious research attention since. The implications for cognitive function are real, though the field is still working out which specific bacterial strains matter most and at what doses.

For anyone interested in the broader territory of cognitive and nootropic supplement UK research, the mechanistic picture is genuinely interesting — it's just that mechanisms alone don't validate a product. You need human trial data, and that's where most brands fall short.

What clinical doses actually look like

Dosing is where the cognitive supplement market gets embarrassing. An ingredient can have solid research behind it and still be useless in a product if the dose is a fraction of what the trials used. This practice — sometimes called "fairy dusting" — is common and I find it genuinely frustrating.

Here's what the RCT data supports for the most-studied ingredients:

• Creatine monohydrate: 3–5g per day in most cognitive trials. Roschel et al. (2021) noted that 5g daily is the most commonly studied dose in brain health research, with loading phases (20g/day for 5–7 days) used in some acute protocols but not necessary for chronic supplementation.
• Lion's Mane mushroom: Docherty et al. (2023) used 1.8g per day in their study on cognitive function and mood in young adults — one of the more rigorous recent trials in this space.
• Probiotics: Doses vary widely by strain. Juan et al. (2022) used a multi-strain probiotic at 40 billion CFU per day in their study on cognitive outcomes — a dose substantially higher than most off-the-shelf products.

The KōJō Daily Formula includes 5,000mg of micronised creatine monohydrate per serving — which sits at the upper end of what cognitive trials have used and matches the dose in Sandkühler et al. (2023). I'm not going to oversell that — creatine is one ingredient, and no single ingredient is the whole story.

The ingredients with genuine promise — and honest caveats

Creatine monohydrate

The most evidence-backed cognitive supplement ingredient available in the UK right now. Multiple RCTs, consistent directional findings, well-understood mechanism, excellent safety profile. The caveat is that effect sizes in healthy, well-nourished adults are modest — this isn't a dramatic cognitive shift, it's a meaningful one under the right conditions.

Lion's Mane mushroom

Docherty et al. (2023) found that Lion's Mane supplementation may support aspects of cognitive function and mood in young adults over a 28-day period, though the authors noted that the sample size (n=41) limits the strength of conclusions. The human data is promising but thin. Animal studies suggest effects on nerve growth factor, but translating that to humans at scale is still a work in progress.

Probiotics and the gut-brain axis

This is an area I find genuinely interesting, partly because the mechanism is so counterintuitive — the idea that gut bacteria may influence cognition via neural and endocrine pathways still surprises people. Jäger et al. (2020) reviewed the evidence on probiotics and noted that certain strains may influence mood and cognitive markers, though they were careful to note that the research is heterogeneous and strain-specific effects matter enormously. Large-scale human cognitive trials are still limited.

Coenzyme Q10 (Ubiquinol)

Ubiquinol — the reduced, more bioavailable form of CoQ10 — has been studied in the context of mitochondrial function and fatigue. Mantle et al. (2024) reviewed CoQ10 supplementation in post-viral fatigue syndrome and found some evidence of benefit in that specific context, though the authors acknowledged that large-scale controlled trials in healthy populations are lacking. I'd be overstating it to frame ubiquinol as a proven cognitive supplement — the research is ongoing.

Glycine and taurine

Both amino acids are studied for roles in neural signalling — glycine as an inhibitory neurotransmitter, taurine for its potential involvement in neurological homeostasis. The honest position is that large-scale human trials on cognitive outcomes specifically are limited for both. Research is ongoing, and I wouldn't make strong claims either way.

What the UK market gets wrong

A few patterns I see repeatedly in the UK cognitive supplement market that are worth naming directly.

Underdosing behind a long ingredients list. A product listing 20 ingredients sounds impressive. But if each one is present at 50mg when the relevant trials used 1,000mg, the list is marketing, not medicine. Check the label. If doses aren't disclosed per ingredient, that's a red flag.

Hiding doses inside a combined formula weight. Some brands list a single total weight for a group of ingredients without breaking down how much of each is actually present. That makes it impossible to assess whether you're getting a meaningful dose of anything. I think this practice is indefensible and I won't do it.

Confusing acute effects with chronic benefit. Caffeine, for instance, may produce acute cognitive effects — Guest et al. (2021) reviewed the evidence extensively — but that's a different claim from saying a product produces lasting cognitive change. Many brands blur this distinction deliberately.

Ignoring the basics. Sleep quality, cortisol levels and sleep, diet, and exercise have larger effects on cognitive function than any supplement. A product that promises to fix your focus while you're sleeping four hours a night and eating poorly is selling you a fantasy.

Who might actually benefit from a cognitive supplement

This is worth being specific about, because the answer isn't "everyone."

People who eat little or no red meat are likely to have lower baseline creatine stores — including brain creatine — and may see more meaningful effects from supplementation. Roschel et al. (2021) noted that vegetarians and vegans tend to show larger cognitive responses to creatine supplementation, which makes biological sense given that dietary creatine is essentially absent from plant-based diets.

People experiencing high cognitive load — demanding work, poor sleep, sustained stress — may also be working with depleted neural energy reserves where creatine's phosphate-buffering role becomes more relevant. Forbes et al. (2022) highlighted sleep deprivation as a condition under which creatine's cognitive effects appear particularly pronounced.

Older adults are another group where the evidence is relatively consistent. McMorris et al. (2008) found that creatine supplementation may support cognitive performance in elderly individuals, with effects on tasks requiring processing speed. Age-related decline in brain creatine synthesis is a plausible mechanism.

If you're a healthy 25-year-old eating well, sleeping well, and exercising regularly, your baseline is already high and the marginal effect of any supplement will be smaller. That's not a reason not to take one — it's just context for expectation-setting.

Frequently asked questions

My honest take

I started KōJō because I was frustrated with the cognitive supplement market — specifically with the gap between what brands claim and what the evidence actually supports. That frustration hasn't gone away. If anything, spending more time in the primary literature has made me more sceptical of bold claims, not less.

Creatine is the ingredient I feel most confident about in this space. The mechanism is sound, the human trial data is consistent, and the safety profile is well-established. It's not a dramatic transformation — it's a modest, real, reproducible effect. I'll take that over a dramatic claim with no data behind it every time.

Everything else — Lion's Mane, probiotics, CoQ10, glycine, taurine — sits somewhere on a spectrum from "interesting early data" to "plausible mechanism, limited human trials." I include some of these in the KōJō Daily Formula because the safety profiles are good and the mechanistic rationale is reasonable, but I'm not going to pretend the evidence is stronger than it is.

What I know for certain is that no supplement is going to compensate for poor sleep, chronic stress, or a diet that's working against you. I've written about how cortisol levels and sleep interact with cognitive function — and the effect sizes there dwarf anything any supplement has demonstrated. Get the basics right first. Then think about whether a cognitive supplement is worth adding.

The UK market will keep selling you hope in capsule form. My job — the one I signed up for when I started this — is to tell you what the evidence actually says, even when that's less exciting than the marketing.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.